HNF4A-AS1 promotes hepatic steatosis in metabolic dysfunction–associated steatotic liver disease by driving HNF4A degradation
Drug Metabolism and Disposition · 2026
DOI: 10.1016/j.dmd.2025.100211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026. Verfasst von Mengyao Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou Universit…. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, RNA, Long Noncoding, Fatty Liver. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Henan Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou University, Zhengzhou, Henan, China.
- State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan,…
- Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou University, Zhengzhou, Henan, China. Electronic address: lrzhang@zzu.edu.cn.
- Department of Pharmacology, School of Basic Medical Sciences, Open and Key Laboratory for Pharmacogenomics at Henan Universities, Zhengzhou University, Zhengzhou, Henan, China. Electronic address: peiwang0707@zzu.edu.cn.
Förderung
- Henan Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Yan, M., Wang, X., Hou, X., Wang, Z., Qiu, Y., Nie, Y., Han, S., Zhang, L., & Wang, P. (2026). HNF4A-AS1 promotes hepatic steatosis in metabolic dysfunction–associated steatotic liver disease by driving HNF4A degradation. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100211
Vancouver
Yan M, Wang X, Hou X, Wang Z, Qiu Y, Nie Y, et al. HNF4A-AS1 promotes hepatic steatosis in metabolic dysfunction–associated steatotic liver disease by driving HNF4A degradation. Drug Metabolism and Disposition. 2026. doi:10.1016/j.dmd.2025.100211
BibTeX
@article{Yan2026,
author = {Yan, Mengyao and Wang, Xiaofei and Hou, Xiaoyang and Wang, Zijing and Qiu, Yanjiao and Nie, Yali and Han, Shengna and Zhang, Lirong and Wang, Pei},
title = {HNF4A-AS1 promotes hepatic steatosis in metabolic dysfunction–associated steatotic liver disease by driving HNF4A degradation},
journal = {Drug Metabolism and Disposition},
year = {2026},
doi = {10.1016/j.dmd.2025.100211}
}
EUVIMED